Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$127.93 USD
-0.88 (-0.68%)
Updated Jan 31, 2025 04:00 PM ET
After-Market: $127.95 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Abbott (ABT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$136.09 | $158.00 | $117.00 | 5.65% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for Abbott comes to $136.09. The forecasts range from a low of $117.00 to a high of $158.00. The average price target represents an increase of 5.65% from the last closing price of $128.81.
Analyst Price Targets (22)
Broker Rating
Abbott currently has an average brokerage recommendation (ABR) of 1.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms. The current ABR compares to an ABR of 1.58 a month ago based on 24 recommendations.
Of the 25 recommendations deriving the current ABR, 17 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 68% and 8% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 16 | 16 | 16 | 16 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.56 | 1.58 | 1.58 | 1.58 | 1.58 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
1/28/2025 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
1/27/2025 | Atlantic Equities | Issie Kirby | Hold | Hold |
1/24/2025 | Daiwa America | Narumi Nakagiri | Strong Buy | Strong Buy |
1/24/2025 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
1/23/2025 | UBS | Danielle Antalffy | Strong Buy | Strong Buy |
1/23/2025 | Mizuho SecuritiesUSA | Anthony Petrone | Hold | Hold |
1/23/2025 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/23/2025 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
1/23/2025 | Not Identified | Not Identified | Hold | Hold |
1/22/2025 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
1/21/2025 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1/2/2025 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
12/13/2024 | Not Identified | Not Identified | Hold | Hold |
11/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/17/2024 | Goldman Sachs | David H Roman | Strong Buy | Strong Buy |
10/14/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
9/29/2024 | Not Identified | Not Identified | Hold | Hold |
8/22/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/19/2024 | William Blair | Margaret K Andrew | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.56 |
ABR (Last week) | 1.58 |
# of Recs in ABR | 25 |
Average Target Price | $136.09 |
LT Growth Rate | 10.40% |
Industry | Medical - Products |
Industry Rank by ABR | 132 of 251 |
Current Quarter EPS Est: | 1.07 |
ABT FAQs
Abbott Laboratories (ABT) currently has an average brokerage recommendation (ABR) of 1.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms.
The average price target for Abbott Laboratories (ABT) is $136.09. The current on short-term price targets is based on 22 reports.
The forecasts for Abbott Laboratories (ABT) range from a low of $117 to a high of $158. The average price target represents a increase of $6.38 from the last closing price of $127.93.
The current UPSIDE for Abbott Laboratories (ABT) is 6.38%
Based on short-term price targets offered by 22 analysts, the average price target for Abbott comes to $136.09. The forecasts range from a low of $117.00 to a high of $158.00. The average price target represents an increase of 5.65% from the last closing price of $128.81.